Primecap Management’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-39,700
Closed -$312K 331
2024
Q3
$312K Hold
39,700
﹤0.01% 333
2024
Q2
$445K Hold
39,700
﹤0.01% 327
2024
Q1
$503K Hold
39,700
﹤0.01% 328
2023
Q4
$545K Sell
39,700
-1,200
-3% -$14K ﹤0.01% 328
2023
Q3
$462K Sell
40,900
-2,800
-6% -$33.5K ﹤0.01% 326
2023
Q2
$584K Sell
43,700
-4,600
-10% -$53.9K ﹤0.01% 321
2023
Q1
$561K Sell
48,300
-17,819
-27% -$210K ﹤0.01% 319
2022
Q4
$795K Sell
66,119
-57,940
-47% -$752K ﹤0.01% 321
2022
Q3
$1.61M Buy
+124,059
New +$1.52M ﹤0.01% 303

Other funds holding BIOX

Primecap Management's BIOX Position: Q4 2024 in Review

Primecap Management sold out of Bioceres Crop Solutions (BIOX) in Q4 2024, closing a stake of 39,700 shares — an estimated $312K sold.

Primecap Management first reported a position in BIOX in Q3 2022 and held it in 9 quarters. The position peaked at $1.61M in Q3 2022. 43 funds tracked by Wall St. Rank hold BIOX as of Q4 2024.

  • Primecap Management reported no remaining Bioceres Crop Solutions position as of Q4 2024 after selling out during the quarter.
  • Primecap Management sold 39,700 Bioceres Crop Solutions shares in Q4 2024, an estimated $312K.
  • Primecap Management first reported a position in Bioceres Crop Solutions in Q3 2022 and held it in 9 quarters.
  • Primecap Management's Bioceres Crop Solutions position peaked at $1.61M in Q3 2022.
  • 43 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2024.

Based on Primecap Management's 13F filing for Q4 2024, filed 10 Feb 2025.